AK Medical Holdings Limited (HKG:1789)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.51
+0.05 (0.92%)
Jul 31, 2026, 4:08 PM HKT

AK Medical Holdings Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4821,4821,3461,0941,052761.44
Revenue Growth
7.15%10.11%23.09%3.98%38.16%-26.46%
Gross Profit
897.4897.4808.19674.49636.44499.19
Operating Income
373.88373.88300.78211.48238.3499.44
Net Income
339.09339.09273.93182.1204.7792.62
Earnings Per Share
0.300.300.240.160.180.08
EPS Growth
16.54%24.18%52.50%-11.11%125.00%-71.43%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Orthopedic Implants - China
1,3551,3551,226993.59977.67687.41
Orthopedic Implants - United Kingdom
170.6170.6164.2152.49116.76125.62
Elimination of Inter-Segment
-43.14-43.14-43.59-52.21-42.38-51.58
Total
1,4821,4821,3461,0941,052761.44

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2451,2451,027729.551,045844.23
Total Debt
86.4386.4399.3984.238.7841.56
Net Cash (Debt)
1,1591,159927.29645.351,007802.67
Net Cash Growth
-15.37%24.99%43.69%-35.89%25.42%-8.52%
Net Cash Per Share
1.041.040.830.580.900.72

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
395.98395.98451.0733.94242.92176.62
Capital Expenditures
-105.67-105.67-152.82-183.8-115.2-58.76
Free Cash Flow
290.31290.31298.25-149.86127.72117.86
Free Cash Flow Growth
-28.93%-2.66%--8.36%-1.79%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.54%60.54%60.03%61.66%60.49%65.56%
Operating Margin
25.22%25.22%22.34%19.33%22.66%13.06%
Pretax Margin
26.64%26.64%23.75%21.13%22.84%14.26%
Profit Margin
22.87%22.87%20.34%16.65%19.46%12.16%
FCF Margin
19.58%19.58%22.15%-13.70%12.14%15.48%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1180.1060.0680.0410.0530.020
Dividend Per Share Growth
63.89%56.73%65.64%-23.04%160.59%-39.53%
Dividend Yield
2.14%2.12%1.54%0.75%0.65%0.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.3416.9818.6835.0147.1964.77
Forward PE
13.3315.2215.7720.9837.2332.47
P/FCF Ratio
18.4519.8317.16-75.6550.90
PS Ratio
3.613.883.805.839.187.88